Interestingly, bile acid receptor activation of FXR and TGR5 can relieve metabolic diseases, such as obesity, type 2 diabetes, dyslipidemia, NAFLD, and atherosclerosis [163,164]. Here, NR1H4 is linked to metabolic syndrome.